CARUBBI, Francesca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.934
EU - Europa 6.709
AS - Asia 5.978
SA - Sud America 765
AF - Africa 122
OC - Oceania 57
Continente sconosciuto - Info sul continente non disponibili 6
Totale 24.571
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.735
SE - Svezia 2.164
SG - Singapore 1.877
CN - Cina 1.606
GB - Regno Unito 1.587
IT - Italia 1.067
HK - Hong Kong 819
BR - Brasile 579
VN - Vietnam 495
DE - Germania 472
FI - Finlandia 398
BD - Bangladesh 264
FR - Francia 221
RU - Federazione Russa 214
TR - Turchia 209
UA - Ucraina 194
KR - Corea 181
IN - India 115
CA - Canada 99
ID - Indonesia 88
BG - Bulgaria 85
AR - Argentina 77
NL - Olanda 65
MX - Messico 60
AU - Australia 54
IQ - Iraq 47
JP - Giappone 33
ZA - Sudafrica 32
IE - Irlanda 29
EC - Ecuador 28
EG - Egitto 27
MY - Malesia 27
VE - Venezuela 26
PL - Polonia 25
RO - Romania 25
AE - Emirati Arabi Uniti 24
AT - Austria 22
BE - Belgio 22
ES - Italia 22
PK - Pakistan 21
SA - Arabia Saudita 20
LT - Lituania 19
PH - Filippine 19
UZ - Uzbekistan 17
CO - Colombia 16
CL - Cile 15
DK - Danimarca 15
IR - Iran 15
MA - Marocco 14
TN - Tunisia 14
IL - Israele 13
JO - Giordania 13
CZ - Repubblica Ceca 11
QA - Qatar 11
TH - Thailandia 11
NP - Nepal 10
AZ - Azerbaigian 9
CH - Svizzera 9
DO - Repubblica Dominicana 8
KE - Kenya 8
PE - Perù 8
GR - Grecia 7
HN - Honduras 6
MK - Macedonia 6
PY - Paraguay 6
RS - Serbia 6
TW - Taiwan 6
UY - Uruguay 6
CR - Costa Rica 5
LB - Libano 5
PA - Panama 5
SI - Slovenia 5
DZ - Algeria 4
ET - Etiopia 4
EU - Europa 4
KG - Kirghizistan 4
OM - Oman 4
PT - Portogallo 4
AL - Albania 3
AO - Angola 3
BF - Burkina Faso 3
BO - Bolivia 3
BY - Bielorussia 3
BZ - Belize 3
JM - Giamaica 3
KZ - Kazakistan 3
BH - Bahrain 2
CI - Costa d'Avorio 2
CY - Cipro 2
GE - Georgia 2
GT - Guatemala 2
NG - Nigeria 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
SV - El Salvador 2
XK - ???statistics.table.value.countryCode.XK??? 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
Totale 24.545
Salva come PNG Salva come JPEG
Città #
Stockholm 1.785
Singapore 1.275
Santa Clara 1.133
Southend 1.062
Ashburn 1.005
Fairfield 889
Hong Kong 796
Chandler 659
Woodbridge 642
San Jose 614
Hefei 599
Houston 449
Jacksonville 391
Seattle 347
Wilmington 334
Cambridge 321
Helsinki 313
Dearborn 297
Beijing 272
Ann Arbor 255
London 254
Nyköping 243
Los Angeles 180
Council Bluffs 178
Seoul 178
Cincinnati 171
Ho Chi Minh City 154
New York 145
Modena 132
Hanoi 119
The Dalles 113
Izmir 112
San Diego 104
Chicago 92
Princeton 92
Bremen 83
Milan 83
Sofia 82
Lauterbourg 80
Eugene 70
Buffalo 66
Jakarta 66
Moscow 65
Grafing 61
Des Moines 57
Munich 52
Shanghai 51
São Paulo 49
Dallas 48
Orem 46
Rome 46
Melbourne 42
Falls Church 41
Bologna 37
Reggio Emilia 37
Salt Lake City 34
Columbus 32
Boardman 31
Frankfurt am Main 29
Nuremberg 29
Kent 28
Phoenix 28
Parma 27
Haiphong 26
Montreal 26
Dublin 25
Tokyo 25
Amsterdam 22
Guangzhou 22
Da Nang 21
Toronto 21
Elk Grove Village 20
Atlanta 19
Brooklyn 19
Brussels 19
Nanjing 19
Redwood City 19
Johannesburg 18
Mexico City 18
Naples 18
Mumbai 17
Warsaw 17
Baghdad 16
Chennai 16
Denver 16
Miano 16
Ottawa 16
Tampa 16
Manchester 15
Rio de Janeiro 15
Timisoara 15
Fremont 14
Norwalk 14
Poplar 14
Verona 14
Belo Horizonte 13
Palermo 13
Redondo Beach 13
San Francisco 13
Turku 13
Totale 17.758
Salva come PNG Salva come JPEG
Nome #
"Assay of HMG-CoA reductase activity in the evaluation of cholesterol synthesis in man". 2.047
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 530
A new severity score index for phenotypic classification and evaluation of responses to treatment in type I Gaucher disease 461
Effect of liver cirrhosis on the systemic availability of naltrexone in humans 430
Prevalence and predictors of liver fibrosis evaluated by vibration controlled transient elastography in type 1 Gaucher disease 404
Suppression of bile acid synthesis, but not of hepatic cholesterol 7alpha-hydroxylase expression, by obstructive cholestasis in humans 370
Hypertriglyceridaemia and low plasma HDL in a patient with apolipoprotein A-V deficiency due to a novel mutation in the APOA5 gene 360
Management of bone disease in Gaucher disease type 1: clinical practice 359
Nutrition in adult patients with selected lysosomal storage diseases 358
Effects of bariatric and metabolic surgical procedures on dyslipidemia: a retrospective, observational analysis. 354
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 354
Herpesvirus DNA is frequently detected in liver tissue from hepatitis C patients 349
The association of Mediterranean diet and exercise modifications with anthropometric parameters in a psychiatric community population: A pilot study 346
Effects of bile duct ligation and cholic acid treatment on fatty liver in two rat models of non-alcoholic fatty liver disease 340
Growth of human herpesvirus 6 in HepG2 cells 324
Statins and nonalcoholic fatty liver disease in the era of precision medicine: More friends than foes 321
Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology. 314
Comparative cytotoxic and cytoprotective effects of taurohyodeoxycholic acid (THDCA) and tauroursodeoxycholic acid (TUDCA) in HepG2 cell line. 307
Effectiveness of dietetic counselling in lowering plasma cholesterol of children affected by hypercholesterolemia 306
Cholesterol esterase activity of human intestinal mucosa 303
Regulation of bile acid synthesis in humans: effect of treatment with bile acids, cholestyramine or simvastatin on cholesterol 7 alpha-hydroxylation rates in vivo. 298
Short-term effects of simvastatin on bile acid synthesis and biliary lipid secretion in human subjects. 292
Short-term multidisciplinary non-pharmacological intervention is effective in reducing liver fat content assessed non-invasively in patients with nonalcoholic fatty liver disease (NAFLD) 292
Transport of sulfobromophthalein and taurocholate in the HepG2 cell line in relation to the expression of membrane carrier proteins 288
Il pool degli acidi biliari quale regolatore del metabolismo epatico del colesterolo: sintesi degli acidi biliari. 288
New motor outcome function measures in evaluation of late-onset Pompe disease before and after enzyme replacement therapy 286
The time has come to look for metabolic dysfunction-associated fatty liver disease in adult patients with type 1 Gaucher disease 280
Observational clinical study in juvenile-adult glycogenosis type 2 patients undergoing enzyme replacement therapy for up to 4 years 272
Anatomia e fisiologia delle vie biliari 270
Review article: effect of bile salt pool composition on hepatic and biliary functions 270
Bile acid structure and regulation of biliary protein secretion and composition in man 267
Global multi-stakeholder endorsement of the MAFLD definition 265
Effect of taurohyodeoxycholic acid on biliary lipid secretion in humans 261
MOLECULAR REGULATION OF STEROL METABOLISM BY BILE ACIDS IN CULTURED HUMAN HEPATOCYTES 259
Association of nonalcoholic fatty liver disease (Nafld) with peripheral diabetic polyneuropathy: A systematic review and meta-analysis 256
Fabry disease: raising awareness of the disease among physicians 255
"Bile acid synthesis: metabolism of 3B-OH-5-cholenoic acid to chenodeoxycholic acid" 252
Nonalcoholic fatty liver disease induced by leuprorelin acetate 251
Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) 251
Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study 250
Liver steatosis is highly prevalent and is associated with metabolic risk factors and liver fibrosis in adult patients with type 1 Gaucher disease 248
Energy balance, glucose and lipid metabolism, cardiovascular risk and liver disease burden in adult patients with type 1 Gaucher disease 247
Atrial Dysfunction Assessed by Cardiac Magnetic Resonance as an Early Marker of Fabry Cardiomyopathy 245
Dietary evaluation and metabolic alterations in HIV-related lipodystrophy 243
Patogenesi della colelitiasi. I. Colelitiasi colesterinica. 236
Effect of diabetic autonomic neuropathy on gallbladder kinetics in insulin dependent diabetic patients 235
Effect of small doses of deoxycholic acid on bile cholesterol saturation in patients with liver cirrhosis 233
Bile acid and hepatocyte death 226
Erratum to: Management of Bone Disease in Gaucher Disease Type 1: Clinical Practice 224
Fertility and pregnancy in women affected by glycogen storage disease type I, results of a multicenter Italian study 223
Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study 222
Cholesterol Esterase Activity of human intestinal mucosa 216
Minimal disease activity in Gaucher disease: criteria for definition 216
Effect of aging on cholesterol 7 alpha-hydroxylation in humans 215
Cholesterol esterase activity of human intestinal mucosa 214
Gaucher Disease in Bone: From Pathophysiology to Practice 208
A case of statin-induced liver injury with positive rechallenge with a second statin. Is there a class effect? 208
Parkinson's disease in Gaucher disease patients: What's changing in the counseling and management of patients and their relatives? 206
Hyperferritinemia and diagnosis of type 1 Gaucher disease 204
MECCANISMI DI CITOTOSSICITÀ DEGLI ACIDI BILIARI. 195
Prevalence rates of gallstone disease in Italy: the Chianciano population study 190
Regulation of cholesterol absorption in humans 188
Rupture d'un anevrysme de l'aorte infecté par salmonelle. 185
EFFECT OF CHENODEOXYCHOLIC ACID AND URSODEOXYCHOLIC ACID ADMINISTRATION ON ACYL-COA - CHOLESTEROL ACYLTRANSFERASE ACTIVITY IN HUMAN LIVER 184
Regulation of bile acid synthesis in humans: studies on cholesterol 7alpha-hydroxylation 'in vivo' 183
Patogenesi della colelitiasi 182
Acid sphingomyelinase deficiency (ASMD): addressing knowledge gaps in unmet needs and patient journey in Italy-a Delphi consensus 181
Quality of life in adult patients with glycogen storage disease type i: Results of a multicenter Italian study 180
Effect of taurohyodeoxycholic acid on biliary lipid secretion in man: preliminary report. 174
Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolaemia: insights from the Italian LIPIGEN Registry 171
Effects of bile acid pool composition on hepatic metabolism of cholesterol in man 171
Nuove prospettive terapeutiche con acidi biliari. 170
Inquadramento delle sindromi colestatiche. 168
Liver involvement in Gaucher disease: A practical review for the hepatologist and the gastroenterologist 167
Deoxycholic acid (DCA) feeding induces significant changes of biliary lipid composition in cirrhotic patients 166
Regulation of bile acid synthesis in humans 165
Cholesterol esterase activity in the small bowel of humans 161
Dislipidemie.In Teodori 2004. Trattato italiano di medicina interna 158
A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease 157
Malattie delle vie biliari 148
Incidence of colorectal cancer and polyps in a health care district: experience at 1 year of registration 148
LA SECREZIONE LIPIDICA BILIARE 147
Liver metastases from carcinoid tumor: Imaging patterns 147
Trabecular complexity as an early marker of cardiac involvement in Fabry disease 145
Effect of feeding small doses of deoxycholic acid on bile lipid composition in patients with liver cirrhosis 135
Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study 135
Tenofovir treatment in HIV-related lipodystrophy syndrome. Retrospective observational forty-eight weeks follow-up study 134
Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia 133
Refinement of the diagnostic approach for the identification of children and adolescents affected by familial hypercholesterolemia: Evidence from the LIPIGEN study 133
Effect of Chenodeoxycholic acid and Ursodeoxycholic acid administration on acyl-CoA: cholesterol acyl tranferase activity in human liver. 133
Pancreatic cholesterol esterase of intestinal mucosa: characterization of enzymatic activity in humans 131
Similarities and differences between Gaucher disease and acid sphingomyelinase deficiency: An algorithm to support the diagnosis 118
Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia 110
Fattori di rischio della litiasi biliare: importanza dell'alimentazione 109
Enzyme replacement therapy improves erythropoiesis and iron dysregulation in Gaucher disease 107
Long-term bone outcomes in Italian patients with Gaucher disease type 1 or type 3 treated with imiglucerase: A sub-study from the International Collaborative Gaucher Group (ICGG) Gaucher Registry 106
Long-term outcome of a cohort of Italian patients affected with alpha-Mannosidosis 100
Towards needed improvements in inherited metabolic medicine in adulthood: The SIMMESN adult metabolic working group and MetabERN Joint Position Statement 100
How to overcome barriers to the implementation of prevention and management strategies of atherosclerotic cardiovascular disease through lipid-lowering therapy 97
Twelve Variants Polygenic Score for Low-Density Lipoprotein Cholesterol Distribution in a Large Cohort of Patients With Clinically Diagnosed Familial Hypercholesterolemia With or Without Causative Mutations 89
Totale 24.710
Salva come PNG Salva come JPEG
Categoria #
all - tutte 86.607
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 86.607
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021101 0 0 0 0 0 0 0 0 0 0 0 101
2021/20221.764 89 202 125 121 94 148 71 64 196 126 370 158
2022/20231.755 164 165 126 188 244 293 34 168 190 29 85 69
2023/20241.042 37 62 59 86 232 93 101 137 22 56 51 106
2024/20254.140 134 54 61 279 750 581 343 211 353 205 543 626
2025/20269.735 484 339 643 781 1.062 597 1.140 346 2.548 775 567 453
Totale 24.710